TBL2
Reaktivität: Human
WB, ELISA, IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,ELISA 1:5000,IF 1:50-200
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
TBL2
(Transducin (Beta)-Like 2 (TBL2))
Andere Bezeichnung
TBL2
Hintergrund
TBL2, WBSCR13, Transducin beta-like protein 2, WS beta-transducin repeats protein, WS-betaTRP, Williams-Beuren syndrome chromosomal region 13 proteinTBL2 encodes a member of the beta-transducin protein family. Most proteins of the beta-transducin family are involved in regulatory functions. transducin beta like 2 is possibly involved in some intracellular signaling pathway. TBL2 is deleted in Williams-Beuren syndrome, a developmental disorder caused by deletion of multiple genes at 7q11.3.